A phase I study of oral vinorelbine and paclitaxel in metastatic breast cancer

被引：0
|
作者：
Delva, Remi [1 ]
Tubiana-Mathieu, Nicole [2 ]
Pienkowski, Tadeusz [3 ]
Vanhoeffer, Udo [4 ]
Denes, Sandrine Lavau [2 ]
Bauer, Barbara [3 ]
Welt, Anja [4 ]
Colin, Celine [5 ]
de Micheaux, Sylvie Lafaye [5 ]
机构：
[1] Ctr Paul Papin, Angers, France
[2] Ctr Hosp Univ, Unite Concertat Pluridisciplinaire Cancerol, Limoges, France
[3] Ctr Oncol, Klin Nowotworow Sutka, Warsaw, Poland
[4] Univ Klinikum Essen, Essen, Germany
[5] Inst Rech Pierre Fabre, Boulogne, France
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：44 / 45
页数：2
相关论文
共 50 条
  • [21] Phase I-II study of oral vinorelbine (NVBO) and capecitabine (X) in metastatic breast cancer (MBC): Results of the phase I trial
    Anton, A.
    Lluch, A.
    Casado, A.
    Provencio, M.
    Munoz, M.
    Lao, J.
    Bermejo, B.
    Paules, A. B.
    Gayo, J.
    Martin, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] Phase II study of paclitaxel plus vinorelbine in metastatic breast cancer patients with prior anthracycline exposure
    Martin, M
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 30 - 30
  • [23] Weekly combination of docetaxel and vinorelbine in metastatic breast cancer: A phase I/II study
    Cals, L
    Nouyrigat, P
    Valenza, B
    Pedinelli, FJ
    Juin, P
    ONCOLOGY, 2004, 67 (3-4) : 257 - 261
  • [24] Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer
    Welt, A
    von Minckwitz, G
    Oberhoff, C
    Borquez, D
    Schleucher, R
    Loibl, S
    Harstrick, A
    Kaufmann, A
    Seeber, S
    Vanhoefer, U
    ANNALS OF ONCOLOGY, 2005, 16 (01) : 64 - 69
  • [25] A phase I/II study of the combination of lapatinib and oral vinorelbine in HER2 positive metastatic breast cancer
    Chen, T. W-W
    Yeh, D-C
    Chao, T-Y
    Lin, C-H
    Chow, L. W-C
    Hsieh, Y-Y
    Huang, S-M
    Cheng, A-L
    Huang, C-S
    Lu, Y-S
    CANCER RESEARCH, 2016, 76
  • [26] A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer
    Chen, Tom Wei-Wu
    Yeh, Dah-Cherng
    Chao, Tsu-Yi
    Lin, Ching-Hung
    Chow, Louis Wing-Cheong
    Chang, Dwan-Ying
    Hsieh, Yao-Yu
    Huang, Shu-Min
    Cheng, Ann-Lii
    Lu, Yen-Shen
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (03) : 242 - 247
  • [27] Phase I/II study of carboplatin, vinorelbine and capecitabine in metastatic breast cancer.
    Rabinowitz, MJ
    Mangalik, A
    Lee, FC
    Cathcart, C
    Verschraegen, C
    Rabinowitz, I
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 57S - 57S
  • [28] Phase I/II Trial of Vinorelbine and Sorafenib in Metastatic Breast Cancer
    Luu, Thehang
    Frankel, Paul
    Chung, Cathie
    Chow, Warren
    Mortimer, Joanne
    Hurria, Arti
    Somlo, George
    CLINICAL BREAST CANCER, 2014, 14 (02) : 94 - 100
  • [29] Phase I trial of vinorelbine and sorafenib in metastatic breast cancer (MBC)
    Luu, T. H.
    Frankel, P. H.
    Chung, C. T.
    Mortimer, J. E.
    Hurria, A.
    McNamra, M.
    Koehler, S.
    Somlo, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer
    Ibrahim, NK
    Valero, V
    Theriault, RL
    Willey, J
    Walters, RS
    Buzdar, AU
    Booser, DJ
    Hortobagyi, GN
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (02): : 117 - 121
12345